LifeMD, Inc. — Director's Dealing 2025

Apr 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2025-03-31

Reporting Person: STAN MARIA E. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-15	Common Stock	A	9375	—	Acquired	77500	Direct
2022-02-04	Common Stock	A	10000	—	Acquired	87500	Direct
2023-11-07	Common Stock	A	40000	—	Acquired	127500	Direct
2023-11-07	Common Stock	A	40000	—	Acquired	167500	Direct
2025-03-31	Common Stock	A	20000	—	Acquired	187500	Direct
2025-03-31	Common Stock	A	20000	—	Acquired	207500	Direct

Footnotes

F1: 3,125 restricted stock units vested on each July 15, 2022, July 15, 2023 and July 15, 2024.

F2: 5,000 restricted stock units vested on each February 4, 2023 and February 4, 2024.

F3: Restricted stock units vested on January 1, 2024.

F4: Restricted stock units vested on January 1, 2025.

F5: Represents grant of performance stock which vested on March 31, 2025.

F6: The restricted stock units vest in full on January 1, 2027.